Increase the proportion of adults with diabetes who get a yearly urinary albumin test ā€” D‑05 Data Methodology and Measurement

About the National Data

Data

Baseline: 48.4 percent of Medicare beneficiaries with diabetes mellitus had urinary albumin testing in 2016

Target: 66.4 percent

Numerator
Number of Medicare beneficiaries with diabetes mellitus undergoing at least annual urinary albumin testing.
Denominator
Number of Medicare beneficiaries with diabetes mellitus.
Target-setting method

Projection

Target-setting method details
Linear trend fitted using weighted least squares and a projection at the 50 percent prediction interval.
1
Target-setting method justification
Trend data were evaluated for this objective. Using historical data points, a trend line was fitted using weighted least squares and the trend was projected into the next decade. This method was used because three or more comparable data points were available, the projected value was within the range of possible values, and a projection at the 50 percent prediction interval was selected because no additional information could be used to assess the trend line so the target was based on the projection.

Methodology

Methodology notes

Data for previous years are recalculated for each Annual Data Report from the USRDS data, due to data collection procedures and delay of reporting of some information to the USRDS database. Values displayed are revised accordingly. Codes used to determine urinary albumin testing are taken directly from the Health Plan Employer Data and Information Set (HEDIS) 2002 specification. HEDIS is a set of standardized measures designed to ensure that purchasers and consumers have the information they need to reliably compare the performance of managed health care plans. They are CPT (current procedure and terminology) codes 82042, 82043, and 82044. CPT is a listing of descriptive terms and identifying codes for reporting medical services and procedures. The cohort includes patients enrolled in Medicare before January 1 of each year, alive and remaining in the program through December 31, and who have diabetes diagnosed during the same year. Patients enrolled in an HMO, or with Medicare as secondary payer, or diagnosed with ESRD during the year are excluded. Urine albumin testing is tracked in each year. Age is calculated on Dec. 31 of each year.

History

Comparable HP2020 objective
Retained, which includes core objectives that are continuing from Healthy People 2020 with no change in measurement.
Revision History
Revised. 

Data for previous years are recalculated for each Annual Data Report from the USRDS data, due to data collection procedures and delay of reporting of some information to the USRDS database. Values displayed are revised accordingly. As a result, in 2021 the baseline was revised from 48.7% to 48.4% of Medicare beneficiaries with diabetes obtained an annual urinary albumin measurement in 2016. The target was revised from 66.6% to 66.4% using the original target setting method.


1. Because Healthy People 2030 objectives have a desired direction (e.g., increase or decrease), the confidence level of a one-sided prediction interval can be used as an indication of how likely a target will be to achieve based on the historical data and fitted trend.